NCT05822934View on ClinicalTrials.gov

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Urinary Bladder Cancer
Interventions
DRUG

Carboplatin-Gemcitabine Cisplatin-Gemcitabine

Carboplatin-gemcitabine versus cisplatin-gemcitabine as neoadjuvant chemotherapy for treatment of muscle invasive urinary bladder cancer

Trial Locations (1)

Unknown

AssiutU, Asyut

All Listed Sponsors
lead

Assiut University

OTHER